Catalyst Wire Dossier Catalyst Wire Dossier

Daclizumab (Zenapax)

daclizumab · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Daclizumab (Zenapax), covering 2016-01-13 to 2016-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax) [Phase 4]

See pricing